Loading...
•
Jun 30, 2021
Hims & Hers Q2 2021 Earnings Report
Revenue increased and the company invested in infrastructure and technologies.
Key Takeaways
Hims & Hers Health, Inc. reported a 69% year-over-year increase in revenue to $60.7 million for Q2 2021. The company is focused on building a unified consumer platform across multiple medical specialties.
Revenue was $60.7 million for the second quarter 2021 compared to $35.9 million for the second quarter 2020, an increase of 69% year-over-year.
Net loss was $(9.2) million for the second quarter 2021 compared to $(1.0) million for the second quarter 2020.
Gross margin was 78% for the second quarter 2021 compared to 71% for the second quarter 2020.
Adjusted EBITDA was $(4.7) million for the second quarter 2021 compared to $1.2 million for the second quarter 2020.
Revenue by Segment
Forward Guidance
For the third quarter 2021, Hims & Hers expects revenue to be in the range of $69 million to $71 million and Adjusted EBITDA to be in the range of $(9) million to $(11) million. For the full year 2021, the company expects revenue to be in the range of $251 million to $255 million and Adjusted EBITDA to be in the range of $(35) million to $(40) million.
Positive Outlook
- Revenue to be in the range of $69 million to $71 million for Q3 2021.
- Adjusted EBITDA to be in the range of $(9) million to $(11) million for Q3 2021.
- Revenue to be in the range of $251 million to $255 million for the full year 2021.
- Adjusted EBITDA to be in the range of $(35) million to $(40) million for the full year 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...